High-dose cytarabine monotherapy is superior to standard-dose cytarabine- based multiagent sequential treatment cycle for consolidation treatment in adult (14-59 years) AML patients according to European Leukemia Net 2022 risk stratification

INTRODUCTION: We firstly investigate based on 2022 European Leukemia Net (ELN) risk stratification, whether standard-dose cytarabine based multiagent sequential chemotherapy (SDMSC) is more beneficial than high-dose cytarabine (HDAC) monotherapy in consolidation for the survival of adult acute myelo...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiaoyu, Liu, Dan, Chen, Erling, Wang, Li, Zhao, Na, Zhou, Li, Tong, Juan, Xue, Lei, Zhang, Lei, Geng, Liangquan, Tang, Baolin, Liu, Huilan, Liu, Xin, Zheng, Changcheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885085/
https://www.ncbi.nlm.nih.gov/pubmed/36727072
http://dx.doi.org/10.3389/fonc.2022.1070588

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885085/
https://www.ncbi.nlm.nih.gov/pubmed/36727072
http://dx.doi.org/10.3389/fonc.2022.1070588

Ejemplares similares